All In Biotech

Drug Trial Radar · NCT06636500

A Phase 1 Study of CG001419 Administered Orally in Healthy Subjects

A Phase 1, Single and Multiple Ascending Dose and Food Effect Study of CG001419 Administered Orally to Evaluate Safety, Tolerability and Pharmacokinetics in Healthy Subjects

Last checked: Nov 20, 2026Latest source record: Feb 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

72

Actual

Start

Jan 22, 2025

Primary completion

Dec 5, 2025

Study completion Dec 5, 2025

Sponsor

Lead sponsor
Cullgen Australia Pty LtdIndustry
Sponsor type
Industry
First posted
Oct 10, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a dose finding study of CG001419, administered as a single dose, with or without food, and as multiple doses. CG001419 is being tested in healthy volunteers in this trial with the goal of eventually developing the drug for patients with pain if it is found to be safe and well tolerated.

Conditions

  • Healthy Volunteer Study
  • Pain Management

Interventions

  • CG001419Drug

    Oral doses

  • PlaceboDrug

    Oral doses

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate the safety and tolerability of single and multiple ascending oral doses of CG001419 in healthy subjectsTime frame: Up to 7 days of dosing

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • CMAX Clinical Research

    Adelaide, South Australia, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.